Krzysztof Palczewski
Krzysztof Palczewski, Ph.D is a Polish biochemist.
His MS and PhD are from the University of Wroclaw and Technical University of Wroclaw respectively (Poland), working with Dr. M. Kochman. His early posts were at the University of Florida and the Oregon Health Sciences University. Dr. Palczewski completed much of his pivotal research at the University of Washington and moved to become the Chair and John H. Hord professor of Pharmacology at Case Western Reserve University in 2005.[1]
He is the founder of two drug discovery companies, Polgenix and Retinagenix.[2]
Contents |
[edit] Research interests
Palczewski's research interest lie in mapping the Visual Transduction System. His work with determining the crystal structure of rhodopsin has given new insight into the function of G protein receptors. This work has led to revolutionary advances in understanding hereditary blindness and can slow retinal degeneration in adults.
[edit] References
[edit] Notes
[edit] Bibliography
- Vertebrate Phototransduction and the Visual Cycle, Krzysztof Palczewski, Academic Press (2000), ISBN 0121822176
